Aragón-Herrera, A.; Feijóo-BandÃn, S.; Anido-Varela, L.; Moraña-Fernández, S.; Roselló-LletÃ, E.; Portolés, M.; Tarazón, E.; Gualillo, O.; González-Juanatey, J.R.; Lago, F.
Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases. J. Pers. Med. 2022, 12, 1021.
https://doi.org/10.3390/jpm12071021
AMA Style
Aragón-Herrera A, Feijóo-BandÃn S, Anido-Varela L, Moraña-Fernández S, Roselló-Lletà E, Portolés M, Tarazón E, Gualillo O, González-Juanatey JR, Lago F.
Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases. Journal of Personalized Medicine. 2022; 12(7):1021.
https://doi.org/10.3390/jpm12071021
Chicago/Turabian Style
Aragón-Herrera, Alana, Sandra Feijóo-BandÃn, Laura Anido-Varela, Sandra Moraña-Fernández, Esther Roselló-LletÃ, Manuel Portolés, EstefanÃa Tarazón, Oreste Gualillo, José Ramón González-Juanatey, and Francisca Lago.
2022. "Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases" Journal of Personalized Medicine 12, no. 7: 1021.
https://doi.org/10.3390/jpm12071021
APA Style
Aragón-Herrera, A., Feijóo-BandÃn, S., Anido-Varela, L., Moraña-Fernández, S., Roselló-LletÃ, E., Portolés, M., Tarazón, E., Gualillo, O., González-Juanatey, J. R., & Lago, F.
(2022). Relaxin-2 as a Potential Biomarker in Cardiovascular Diseases. Journal of Personalized Medicine, 12(7), 1021.
https://doi.org/10.3390/jpm12071021